Technology Transfer

Tech Transfer and Regulatory Compliance

November 15, 2023

Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.

Best Practice Tech Transfer Methods for CGTs

November 01, 2023

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program

October 13, 2023

Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.

BIOVECTRA in Tech Transfer Agreement with Acuitas Therapeutics for LNP Delivery System

October 11, 2023

Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.

Communication is Key in Complex Tech Transfer

May 15, 2023

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Addressing the Key Pitfalls Hindering Technology Transfer Success

November 01, 2022

In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.

Societal CDMO Signs Multiple CDMO Service Agreements

October 25, 2022

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

The Key Elements for Assay Transfer Success

December 01, 2021

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.

Honeywell Completes Remote Control System Migration for Hungarian Pharma Manufacturer

December 03, 2020

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

AbCellera’s Acquisition of OrthoMab Bispecific Platform Propels Antibody Development

August 28, 2020

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.